These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33393070)

  • 1. Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab.
    Abbadessa G; Miele G; Fratta M; Bonavita S
    Acta Neurol Belg; 2021 Oct; 121(5):1341-1342. PubMed ID: 33393070
    [No Abstract]   [Full Text] [Related]  

  • 2. Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions.
    Lambert N; Steinmetz M; Sibille A; Sadzot B
    Ann Neurol; 2021 Jun; 89(6):1255-1256. PubMed ID: 33641185
    [No Abstract]   [Full Text] [Related]  

  • 3. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
    Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
    J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma.
    Akagi Y; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T
    Intern Med; 2020 Apr; 59(8):1075-1080. PubMed ID: 32009093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pembrolizumab induced toxic epidermal necrolysis.
    Kumar R; Bhandari S
    Curr Probl Cancer; 2020 Apr; 44(2):100478. PubMed ID: 31122669
    [No Abstract]   [Full Text] [Related]  

  • 6. Case of dermatomyositis during treatment with pembrolizumab for lung cancer.
    Hinogami H; Yamashita C; Tanaka A; Shirai H; Nakano Y; Matsuura Y
    J Dermatol; 2019 Nov; 46(11):e430-e432. PubMed ID: 31215668
    [No Abstract]   [Full Text] [Related]  

  • 7. Disseminated intravascular coagulation in advanced lung adenocarcinoma during first-line pembrolizumab.
    Alberti A; Mancin M; Cortinovis D; Bidoli P; Sala L
    Immunotherapy; 2020 Jun; 12(9):629-633. PubMed ID: 32418466
    [No Abstract]   [Full Text] [Related]  

  • 8. Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.
    Sugano T; Seike M; Funasaka Y; Yoshida M; Takayama R; Okamura K; Nakanishi A; Tanaka T; Takeuchi S; Noro R; Minegishi Y; Kubota K; Saeki H; Gemma A
    J Immunother Cancer; 2019 Feb; 7(1):59. PubMed ID: 30813943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung adenocarcinoma initially presenting as Trousseau's syndrome treated successfully with pembrolizumab: A case report.
    Nakano Y; Koide N; Koyama Y; Nitta K; Koizumi T
    Thorac Cancer; 2021 Feb; 12(4):557-559. PubMed ID: 33350050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma.
    Kurokawa K; Hara M; Iwakami SI; Genda T; Iwakami N; Miyashita Y; Fujioka M; Sasaki S; Takahashi K
    Intern Med; 2019; 58(22):3283-3287. PubMed ID: 31735738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe pembrolizumab-induced gastritis in a patient with lung adenocarcinoma.
    Pérez Santamaría C; Castillo-López G; Curto García I; Gómez Iglesias P; Lumbreras Cabrera M; Carreira Guillán L
    Rev Esp Enferm Dig; 2022 Feb; 114(2):127-128. PubMed ID: 34743523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.
    Kato M; Mori M; Miura K; Asao T; Motomura H; Nishino K; Ko R; Koyama R; Hayashi T; Takahashi K
    Thorac Cancer; 2021 Nov; 12(22):3076-3079. PubMed ID: 34617405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericardial tamponade during pembrolizumab treatment in a patient with advanced lung adenocarcinoma: A case report and review of the literature.
    Harada K; Ogasawara M; Shido A; Meno A; Oda S; Yoshida S; Yoshida S; Yoshikawa A; Ebata K; Abiko S; Kawagishi N; Sano I; Oda H; Miyagishima T
    Thorac Cancer; 2020 May; 11(5):1350-1353. PubMed ID: 32181993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of late and lethal Trousseau's syndrome induced by pembrolizumab in lung adenocarcinoma.
    Cheng Y; Ouyang W; Jie C; Zhang J; Yu J; Xie C
    Immunotherapy; 2023 Feb; 15(2):71-75. PubMed ID: 36628567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy-intensified paraneoplastic dermatomyositis.
    Estenaga A; Rodriguez-Garijo N; Tomás-Velázquez A; Antoñanzas-Pérez J; Alvarez-Gigli ML; García-Tobar L; Espaa-Alonso A; Salido-Vallejo R
    Indian J Dermatol Venereol Leprol; 2021; 88(1):93-96. PubMed ID: 34491672
    [No Abstract]   [Full Text] [Related]  

  • 16. [Limbic encephalitis].
    Pach J
    Fortschr Neurol Psychiatr; 1994 Sep; 62(9):356-8. PubMed ID: 7959519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired idiopathic generalized anhidrosis following pembrolizumab treatment.
    Furuta K; Horiguchi A; Nakagawa Y; Kambe N; Kogame T
    Clin Exp Dermatol; 2022 Feb; 47(2):463-465. PubMed ID: 34610167
    [No Abstract]   [Full Text] [Related]  

  • 18. Life threatening pembrolizumabinduced myositis in a patient treated for advanced adenocarcinoma of the lung.
    Robinson SD; Lai C; Hotton G; Anand G
    Acute Med; 2019; 18(3):197-199. PubMed ID: 31536059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface marker profiles on lung lymphocytes may predict the mechanism of immune-mediated pneumonitis triggered by tumor-infiltrating lymphocytes in lung cancer patients treated with pembrolizumab.
    Oda K; Kato K; Nakamura M; Jotatsu T; Noguchi S; Kawanami T; Kido T; Yatera K
    Lung Cancer; 2018 Apr; 118():171-172. PubMed ID: 29496324
    [No Abstract]   [Full Text] [Related]  

  • 20. Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report.
    Sackstein P; Zaemes J; Kim C
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.